Racial and ethnic disparities in alzheimer's disease pharmacotherapy exposure: an analysis across four state medicaid populations

Keyphrases

• Four States 100%
• Medicaid Population 100%
• Non-Hispanic 57%
• Memantine 42%
• Florida 42%
• New York 42%
• Race-ethnicity 28%
• Medicaid 14%
• Significant Predictors 14%
• Minority Populations 14%
• Alzheimer's Disease Diagnosis 14%
• Medicare 14%
• Variables of Interest 14%
• Demographic Resources 14%
• New Jersey 14%
• Utilization Factor 14%
• Long-term Care 14%
• Resource Utilization 14%
• Treatment Disparities 14%
• Health Policy Issues 14%
• Oaxaca-Blinder Decomposition 14%
• ICD-9 14%
• Black Hispanic 14%
• Inpatient Care 14%
• Medicaid Program 14%
• Decomposition Method 14%

Medicine and Dentistry

• Alzheimer's Disease 100%
• Memantine 37%
• Acetylcholinesterase Inhibitor 37%
• ICD-9-CM 12%
• Retrospective Study 12%
• Medicaid 12%
• Medicare 12%
• Long-Term Care 12%
• Demography 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Alzheimer's Disease 100%
• Cholinesterase Inhibitor 37%
• Memantine 37%
• ICD-9-CM 12%